Ovarian Cancer Trial, Recruiting NCT06551285 Sponsor: Celia Bañuls Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06551285
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 45 years.
  • People who have been diagnosed with Polycystic Ovary Syndrome (PCOS) using a specific set of diagnostic guidelines known as the AE-PCOS criteria (from 2009).
  • People who are willing to take part in the study and sign a consent form after reading it.

Who may not be able to join:

  • People who have previously taken medications or supplements intended to treat PCOS, such as metformin, hormonal therapies, or inositol.
  • People who have an infectious, blood-related, inflammatory, or autoimmune condition.
  • People who have a serious disease affecting a major organ or body system.
  • People who have a cardiovascular condition such as a heart attack, reduced blood flow to the heart, or blood clots.
  • People who have diabetes.
  • People who have severely high blood pressure.
  • People who have an alcohol dependency problem.
  • People who are currently smoking.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Celia Bañuls
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Verify that nutritional intervention and inositol supplementation improve the symptoms of PCOS.; Evaluate the differences in the diversity of the intestinal microbiota depending on whether patients present PCOS or not.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov